Relapse into opiate and crack cocaine misuse: a scoping review

References

• Adinoff B, Carmody TJ, Walker R, Donovan DM, Brigham GS, Winhusen TM. 2016. Decision-making processes as predictors of relapse and subsequent use in stimulant-dependent patients. Am J Drug Alcohol Abuse. 42(1):88–97.
   PubMed Web of Science ®Google Scholar
• Amaro H, Spear S, Vallejo Z, Conron K, Black DS. 2014. Feasibility, acceptability, and preliminary outcomes of a mindfulness-based relapse prevention intervention for culturally-diverse, low-income women in substance use disorder treatment. Subst Use Misuse. 49(5):547–559.
   PubMed Web of Science ®Google Scholar
• Andersson HW, Wenaas M, Nordfjaern T. 2019. Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances. Addict Behav. 90:222–228.
   PubMed Web of Science ®Google Scholar
• Appiah R, Boakye KE, Ndaa P, Aziato L. 2018. “Tougher than ever”: an exploration of relapse prevention strategies among patients recovering from poly-substance use disorders in Ghana. Drugs Educ Prev Policy. 25(6):467–474.
   Web of Science ®Google Scholar
• Arksey H, O’Malley L. 2005. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 8(1):19–32.
   Google Scholar
• Ashford RD, Brown A, Brown T, Callis J, Cleveland HH, Eisenhart E, Whitney J. 2019. Defining and operationalizing the phenomena of recovery: a working definition from the recovery science research collaborative. Addict Res Theory. 27(3):179–188.
   Web of Science ®Google Scholar
• Babor TF, Cooney NL, Lauerman RJ. 1987. The dependence syndrome concept as a psychological theory of relapse behaviour: an empirical evaluation of alcoholic and opiate addicts. Br J Addict. 82(4):393–405.
   PubMedGoogle Scholar
• Bailey CP, Husbands SM. 2014. Novel approaches for the treatment of psychostimulant and opioid abuse – focus on opioid receptor-based therapies. Expert Opin Drug Discov. 9(11):1333–1344.
   PubMed Web of Science ®Google Scholar
• Bailey GL, Herman DS, Stein MD. 2013. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification. J Subst Abuse Treat. 45(3):302–305.
   PubMed Web of Science ®Google Scholar
• Bandura A. 1977. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 84(2):191–215.
   Google Scholar
• Barreno EM, Domínguez-Salas S, Díaz-Batanero C, Lozano ÓM, Marín JAL, Verdejo-García A. 2019. Specific aspects of cognitive impulsivity are longitudinally associated with lower treatment retention and greater relapse in therapeutic community treatment. J Subst Abuse Treat. 96:33–38.
   PubMed Web of Science ®Google Scholar
• Bashiri M, Mancino MJ, Stanick VA, Thostenson J, Kosten TR, Oliveto AH. 2017. Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: a retrospective analysis of two clinical trials. Am J Addict. 26(8):807–814.
   PubMed Web of Science ®Google Scholar
• Bell RP, Garavan H, Foxe JJ. 2014. Neural correlates of craving and impulsivity in abstinent former cocaine users: towards biomarkers of relapse risk. Neuropharmacology. 85:461–470.
   PubMed Web of Science ®Google Scholar
• Berridge KC, Robinson TE. 2016. Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol. 71(8):670–679.
   PubMed Web of Science ®Google Scholar
• Best D. 2012. Addiction recovery: a movement for social change and personal growth in the UK. Brighton (UK): Pavilion Publishing.
   Google Scholar
• Best D, Lubman DI. 2012. The emergence of a recovery movement for alcohol and drug dependence. Aust N Z J Psychiatry. 46(6):586–586.
   PubMed Web of Science ®Google Scholar
• Blum K, Chen TJH, Bailey J, Bowirrat A, Femino J, Chen ALC, Simpatico T, Morse S, Giordano J, Damle U, et al. 2011. Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? Mol Neurobiol. 44(3):250–268.
   PubMed Web of Science ®Google Scholar
• Bossert JM, Ghitza UE, Lu L, Epstein DH, Shaham Y. 2005. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol. 526(1–3):36–50.
   PubMed Web of Science ®Google Scholar
• Bowen S, Somohano VC, Rutkie RE, Manuel JA, Rehder KL. 2017. Mindfulness-based relapse prevention for methadone maintenance: a feasibility trial. J Altern Complement Med. 23(7):541–544.
   PubMed Web of Science ®Google Scholar
• Bradizza CM, Stasiewicz PR, Paas ND. 2006. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev. 26(2):162–178.
   PubMed Web of Science ®Google Scholar
• Bradley BP, Gossop M, Brewin CR, Phillips G, Green L. 1992. Attributions and relapse in opiate addicts. J Consult Clin Psychol. 60(3):470–472.
   PubMed Web of Science ®Google Scholar
• Branson CE, Clemmey P, Harrell P, Subramaniam G, Fishman M. 2012. Polysubstance use and heroin relapse among adolescents following residential treatment. J Child Adolesc Subst Abuse. 21(3):204–221.
   Web of Science ®Google Scholar
• Bronfenbrenner U. 1992. Ecological systems theory. In Vasta R, editor. Six theories of child development: revised formulations and current issues. London (UK): Jessica Kingsley Publishers; p. 187–249.
   Google Scholar
• Brown BS. 1991. Relapse prevention in substance misuse: introduction. Int J Addict. 25(sup9):1081–1083.
   Web of Science ®Google Scholar
• Brown BS. 1998. Drug use – chronic and relapsing or a treatable condition? Subst Use Misuse. 33(12):2515–2520.
   PubMed Web of Science ®Google Scholar
• Callegari J, Liedgren P, Kullberg C. 2019. Gendered debt–a scoping study review of research on debt acquisition and management in single and couple households. Eur J Soc Work. DOI:10.1080/13691457.2019.1567467
   Web of Science ®Google Scholar
• Carroll KM. 1996. Relapse prevention as a psychosocial treatment: a review of controlled clinical trials. Exp Clin Psychopharmacol. 4(1):46–54.
   Web of Science ®Google Scholar
• Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ. 2004. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients. Arch Gen Psychiatry. 61(3):264.
   PubMed Web of Science ®Google Scholar
• Carroll KM, Rawson RA. 2005. Relapse prevention for stimulant dependence. In Marlatt GA, Gordon JR, editors. Relapse prevention. 1st ed. New York: Guilford Press; p. 130–150.
   Google Scholar
• Chalana H, Kundal T, Gupta V, Malhari AS. 2016. Predictors of relapse after inpatient opioid detoxification during 1-year follow-up. J Addict. 2016:1–7.
   Google Scholar
• Chan D. 2009. So why ask me? Are self-report data really that bad. In Lance CE, Vandenberg RJ, editors. Statistical and methodological myths and urban legends: doctrine, verity and fable in the organizational and social sciences. 1st ed. New York: Routledge; p. 309–336.
   Google Scholar
• Chen L, Li N, Ge S, Lozano A M, Lee D J, Yang C, Li L, Bai Q, Lu H, Wang J, et al. 2019. Long-term results after deep brain stimulation of nucleus accumbens and the anterior limb of the internal capsule for preventing heroin relapse: an open-label pilot study. Brain Stimulation. 12(1):175–183.
   PubMed Web of Science ®Google Scholar
• Chen T, Zhong N, Du J, Li Z, Zhao Y, Sun H, Chen Z, Jiang H, Zhao M. 2019. Polydrug use patterns and their impact on relapse among heroin‐dependent patients in Shanghai, China. Addiction. 114(2):259–267.
   PubMed Web of Science ®Google Scholar
• Cherry K. 2019. How the attentional bias influences the decisions we make [Online]. New York (NY). [accessed 2019 Aug 8]. https://www.verywellmind.com/what-is-an-attentional-bias-2795027.
   Google Scholar
• Christiansen P, Schoenmakers TM, Field M. 2015. Less than meets the eye: reappraising the clinical relevance of attentional bias in addiction. Addict Behav. 44:43–50.
   PubMed Web of Science ®Google Scholar
• Connors GJ, Maisto SA, Donovan DM. 1996. Conceptualizations of relapse: a summary of psychological and psychobiological models. Addiction. 91(s12):S5–S14.
   PubMed Web of Science ®Google Scholar
• D’Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R. 2011. Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study. Biol Psychiatry. 70(8):706–711.
   PubMed Web of Science ®Google Scholar
• D’Souza MS. 2015. Glutamatergic transmission in drug reward: implications for drug addiction. Front Neurosci. 9:404.
   PubMed Web of Science ®Google Scholar
• Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O’Brien C P. 2003. Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend. 70(1):29–37.
   PubMed Web of Science ®Google Scholar
• DeFulio A, Silverman K. 2011. Employment‐based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: post‐intervention outcomes. Addiction. 106(5):960–967.
   PubMed Web of Science ®Google Scholar
• Dejong W. 1994. Relapse prevention: an emerging technology for promoting long-term drug abstinence. Int J Addict. 29(6):681–705.
   PubMed Web of Science ®Google Scholar
• Domínguez-Salas S, Díaz-Batanero C, Lozano-Rojas OM, Verdejo-García A. 2016. Impact of general cognition and executive function deficits on addiction treatment outcomes: systematic review and discussion of neurocognitive pathways. Neurosci Biobehav Rev. 71:772–801.
   PubMed Web of Science ®Google Scholar
• Donovan D, Witkiewitz K. 2012. Relapse prevention: from radical idea to common practice. Addict Res Theory. 20(3):204–217.
   Web of Science ®Google Scholar
• Doukas N, Cullen J. 2010. Recovered addicts working in the addiction field: pitfalls to substance abuse relapse. Drugs Educ Prev Policy. 17(3):216–231.
   Web of Science ®Google Scholar
• Drummond DC. 2001. Theories of drug craving, ancient and modern. Addiction. 96(1):33–46.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. 2019. European drug report 2019: trends and developments. Luxembourg: Publications Office of the European Union.
   Google Scholar
• Evren C, Yilmaz A, Can Y, Bozkurt M, Evren B, Umut G. 2014. Severity of impulsivity and aggression at a 12-month follow-up among male heroin dependent patients. Klin Psikofarmakoloji Bülteni-Bull Clin Psychopharmacol. 24(2):158–167.
   Web of Science ®Google Scholar
• Famitafreshi H, Karimian M. 2018. Cognition is a necessary factor for controlling drug abuse. CPSR. 14(4):252–256.
   Web of Science ®Google Scholar
• Fatseas M, Denis C, Massida Z, Verger M, Franques-Rénéric P, Auriacombe M. 2011. Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals. Biol Psychiatry. 70(8):720–727.
   PubMed Web of Science ®Google Scholar
• Flynn PM, Brown BS. 2015. Misrepresenting the accomplishments of treatment. Subst Use Misuse. 50(8–9):978–980.
   PubMed Web of Science ®Google Scholar
• Forray A, Merry B, Lin H, Ruger JP, Yonkers KA. 2015. Perinatal substance use: a prospective evaluation of abstinence and relapse. Drug Alcohol Depend. 150:147–155.
   PubMed Web of Science ®Google Scholar
• Forster SE, Dickey MW, Forman SD. 2018. Regional cerebral blood flow predictors of relapse and resilience in substance use recovery: a coordinate-based meta-analysis of human neuroimaging studies. Drug Alcohol Depend. 185:93–105.
   PubMed Web of Science ®Google Scholar
• Forster SE, Finn PR, Brown JW. 2017. Neural responses to negative outcomes predict success in community-based substance use treatment. Addiction. 112(5):884–896.
   PubMed Web of Science ®Google Scholar
• Garavan H, Brennan K, Hester R, Whelan R. 2013. The neurobiology of successful abstinence. Curr Opin Neurobiol. 23(4):668–674.
   PubMed Web of Science ®Google Scholar
• Gawrysiak MJ, Jagannathan K, Regier P, Suh JJ, Kampman K, Vickery T, Childress AR. 2017. Unseen scars: cocaine patients with prior trauma evidence heightened resting state functional connectivity (RSFC) between the amygdala and limbic-striatal regions. Drug Alcohol Depend. 180:363–370.
   PubMed Web of Science ®Google Scholar
• Geng X, Hu Y, Gu H, Salmeron BJ, Adinoff B, Stein EA, Yang Y. 2017. Salience and default mode network dysregulation in chronic cocaine users predict treatment outcome. Brain. 140(5):1513–1524.
   PubMed Web of Science ®Google Scholar
• Godley SH, Dennis ML, Godley MD, Funk RR. 2004. Thirty‐month relapse trajectory cluster groups among adolescents discharged from out‐patient treatment. Addiction. 99:129–139.
   PubMed Web of Science ®Google Scholar
• Goeders NE. 2003. The impact of stress on addiction. Eur Neuropsychopharmacol. 13(6):435–441.
   PubMed Web of Science ®Google Scholar
• Goldstein A. 1972. Heroin addiction and the role of methadone in its treatment. Arch Gen Psychiatry. 26(4):291.
   PubMed Web of Science ®Google Scholar
• Gorski TT. 1990. The cenaps model of relapse prevention: basic principles and procedures. J Psychoact Drugs. 22(2):125–133.
   PubMed Web of Science ®Google Scholar
• Gossop M, Green L, Phillips G, Bradley B. 1989. Lapse, relapse and survival among opiate addicts after treatment. Br J Psychiatry. 154(3):348–353.
   PubMed Web of Science ®Google Scholar
• Gossop M, Stewart D, Browne N, Marsden J. 2002. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction. 97(10):1259–1267.
   PubMed Web of Science ®Google Scholar
• Haug NA, Sorensen JL, Gruber VA, Song YS. 2005. Relapse prevention in opioid dependence. In Marlatt GA, Donovan DM, editors. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. 2nd ed. New York: Guilford Press; p. 151–178.
   Google Scholar
• Heather N, Best D, Kawalek A, Field M, Lewis M, Rotgers F, Wiers R.W, Heim D. 2018. Challenging the brain disease model of addiction: European launch of the addiction theory network. Addict Res Theory. 26(4):249–255.
   Web of Science ®Google Scholar
• Hser YI, Grella C, Chou CP, Anglin MD. 1998. Relationships between drug treatment careers and outcomes: findings from the National Drug Abuse Treatment Outcome Study. Eval Rev. 22(4):496–519.
   Web of Science ®Google Scholar
• Hudson A, Stamp JA. 2011. Ovarian hormones and propensity to drug relapse: a review. Neurosci Biobehav Rev. 35(3):427–436.
   PubMed Web of Science ®Google Scholar
• Huhn A S, Harris J, Cleveland HH, Lydon D M, Stankoski D, Cleveland M J, Deneke E, Bunce S C. 2016. Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence. Brain Res Bull. 123:94–101.
   PubMed Web of Science ®Google Scholar
• Hyman SM, Paliwal P, Chaplin TM, Mazure CM, Rounsaville BJ, Sinha R. 2008. Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend. 92(1–3):208–216.
   PubMed Web of Science ®Google Scholar
• Ivers J.-H, Zgaga L, Sweeney B, Keenan E, Darker C, Smyth BP, Barry J. 2017. A naturalistic longitudinal analysis of post-detoxification outcomes in opioid-dependent patients. Drug Alcohol Rev. 37:S339–S347.
   PubMed Web of Science ®Google Scholar
• Kantak KM. 2003. Anti-cocaine vaccines: antibody protection against relapse. Expert Opin Pharmacother. 4(2):213–218.
   PubMed Web of Science ®Google Scholar
• Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. 2019. Drug overdose deaths involving cocaine and psychostimulants with abuse potential – United States, 2003–2017. MMWR Morb Mortal Wkly Rep. 68(17):388–395.
   PubMed Web of Science ®Google Scholar
• Kelly JF, White WL. 2010. Recovery management and the future of addiction treatment and recovery in the USA. In Kelly JF, White WL, editors. Addiction recovery management: theory, research and practice. New York: Humana Press; p. 303–316.
   Google Scholar
• Khantzian EJ. 2011. Fine-tuning on painful affect and relapse: a group vignette. J Groups Addict Recov. 6(3):264–271.
   Google Scholar
• Krenek M, Maisto SA. 2013. Life events and treatment outcomes among individuals with substance use disorders: a narrative review. Clin Psychol Rev. 33(3):470–483.
   PubMed Web of Science ®Google Scholar
• Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, Burakov A, Masalov D, Romanova T N, Palatkin V, et al. 2013. Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend. 132(3):674–680.
   PubMed Web of Science ®Google Scholar
• LaRowe SD, Kalivas PW, Nicholas JS, Randall PK, Mardikian PN, Malcolm RJ. 2013. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 22(5):443–452.
   PubMed Web of Science ®Google Scholar
• Levi Bolin B, Alcorn JL, Lile JA, Rush CR, Rayapati AO, Hays LR, Stoops WW. 2017. N -Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. Drug Alcohol Depend. 178:452–460.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu J, Wang W, Wang Y, Li W, Chen J, Zhu J, Yan X, Li Y, Li Z, et al. 2018. Disrupted coupling of large-scale networks is associated with relapse behaviour in heroin-dependent men. JPN. 43(1):48–57.
   Web of Science ®Google Scholar
• Li W, Zhu J, Li Q, Ye J, Chen J, Liu J, Li Z, Li Y, Yan X, Wang Y, et al. 2016. Brain white matter integrity in heroin addicts during methadone maintenance treatment is related to relapse propensity. Brain Behav. 6(2):n/a–n/a.
   Web of Science ®Google Scholar
• Llorente JM, Fernández C, Gutiérrez M. 2000. Prediction of relapse among heroin users treated in Spanish therapeutic communities. A comparison of different models. Subst Use Misuse. 35(11):1537–1550.
   PubMed Web of Science ®Google Scholar
• LoBue C, Cullum CM, Braud J, Walker R, Winhusen T, Suderajan P, Adinoff B. 2014. Optimal neurocognitive, personality and behavioral measures for assessing impulsivity in cocaine dependence. Am J Drug Alcohol Abuse. 40(6):455–462.
   PubMed Web of Science ®Google Scholar
• Lopes-Rosa R, Kessler F P, Pianca T G, Guimarães L, Ferronato P, Pagnussat E, Moura H, Pechansky F, von Diemen L. 2017. Predictors of early relapse among adolescent crack users. J Addict Dis. 36(2):136–143.
   PubMed Web of Science ®Google Scholar
• Luo X, Zhang S, Hu S, Bednarski SR, Erdman E, Farr OM, Hong K-I, Sinha R, Mazure CM, Li C-SR. 2013. Error processing and gender-shared and-specific neural predictors of relapse in cocaine dependence. Brain. 136(4):1231–1244.
   PubMed Web of Science ®Google Scholar
• Maehira Y, Chowdhury E, Reza M, Drahozal R, Gayen T, Masud I, Afrin S, Takamura N, Azim T. 2013. Factors associated with relapse into drug use among male and female attendees of a three-month drug detoxification–rehabilitation programme in Dhaka, Bangladesh: a prospective cohort study. Harm Reduct J. 10(1):14.
   PubMed Web of Science ®Google Scholar
• Marhe R, Luijten M, Van De Wetering BJ, Smits M, Franken IH. 2013. Individual differences in anterior cingulate activation associated with attentional bias predict cocaine use after treatment. Neuropsychopharmacology. 38(6):1085–1093.
   PubMed Web of Science ®Google Scholar
• Marhe R, van de Wetering BJ, Franken IH. 2013. Error-related brain activity predicts cocaine use after treatment at 3-month follow-up. Biol Psychiatry. 73(8):782–788.
   PubMed Web of Science ®Google Scholar
• Marhe R, Waters AJ, van de Wetering BJ, Franken IH. 2013. Implicit and explicit drug-related cognitions during detoxification treatment are associated with drug relapse: an ecological momentary assessment study. J Consult Clin Psychol. 81(1):1–12.
   PubMed Web of Science ®Google Scholar
• Marissen MA, Franken IH, Waters AJ, Blanken P, Van Den Brink W, Hendriks VM. 2006. Attentional bias predicts heroin relapse following treatment. Addiction. 101(9):1306–1312.
   PubMed Web of Science ®Google Scholar
• Marlatt GA. 1985. Relapse prevention: theoretical rationale and overview of the model. In Marlatt GA, Gordon JR, editors. Relapse prevention. 1st ed. New York (NY): Guilford Press; p. 280–250.
   Google Scholar
• Marlatt GA. 1996. Lest taxonomy become taxidermy: a comment on the relapse replication and extension project. Addiction. 91(s12):S147–S154.
   PubMed Web of Science ®Google Scholar
• Marlatt GA, Witkiewitz K. 2005. Relapse prevention for alcohol and drug problems. In Marlatt GA, Donovan DM, editors. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York (NY): The Guilford Press; p. 1–44.
   Google Scholar
• Maulik PK, Tripathi B, Pal HR. 2002. Coping behaviors and relapse precipitants in opioid dependence. J Subst Abuse Treat. 22(3):135–140.
   PubMed Web of Science ®Google Scholar
• McAuliffe WE. 1982. A test of Wikler’s theory of relapse: the frequency of relapse due to conditioned withdrawal sickness. Int J Addict. 17(1):19–33.
   PubMed Web of Science ®Google Scholar
• McAuliffe WE. 1990. A randomized controlled trial of recovery training and self-help for opioid addicts in New England and Hong Kong. J Psychoact Drugs. 22(2):197–209.
   PubMed Web of Science ®Google Scholar
• McHugh MJ, Demers CH, Braud J, Briggs R, Adinoff B, Stein EA. 2013. Striatal-insula circuits in cocaine addiction: implications for impulsivity and relapse risk. Am J Drug Alcohol Abuse. 39(6):424–432.
   PubMed Web of Science ®Google Scholar
• McHugh MJ, Demers CH, Salmeron BJ, Devous MD, Stein EA, Adinoff B. 2014. Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals. Front Psychiatry. 5:16.
   PubMed Web of Science ®Google Scholar
• McIntosh J, McKeganey N. 2000. The recovery from dependent drug use: addicts’ strategies for reducing the risk of relapse. Drugs Educ Prev Policy. 7(2):179–192.
   Web of Science ®Google Scholar
• McKay JR, Franklin TR, Patapis N, Lynch KG. 2006. Conceptual, methodological, and analytical issues in the study of relapse. Clin Psychol Rev. 26(2):109–127.
   PubMed Web of Science ®Google Scholar
• McKay JR, Rutherford MJ, Alterman AI, Cacciola JS. 1996. Development of the Cocaine Relapse Interview: an initial report. Addiction. 91(4):535–548.
   PubMed Web of Science ®Google Scholar
• McKeganey N, Morris Z, Neale J, Robertson M. 2004. What are drug users looking for when they contact drug services: abstinence or harm reduction? Drugs Educ Prev Policy. 11(5):423–435.
   Web of Science ®Google Scholar
• McLellan AT, Lewis D C, O’Brien C P, Kleber H D. 2000. Drug dependence, a chronic medical illness. JAMA. 284(13):1689.
   PubMed Web of Science ®Google Scholar
• McMahon RC. 2001. Personality, stress, and social support in cocaine relapse prediction. J Subst Abuse Treat. 21(2):77–87.
   PubMed Web of Science ®Google Scholar
• Moeller SJ, Paulus MP. 2018. Toward biomarkers of the addicted human brain: using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 80:143–154.
   PubMed Web of Science ®Google Scholar
• Mohammadpoorasl A, Fakhari A, Akbari H. 2012. Addiction relapse and its predictors: a prospective study. J Addict Res Ther. 03(01):1–3.
   Google Scholar
• Mullen K, Hammersley R. 2006. Attempted cessation of heroin use among men approaching mid-life. Drugs Educ Prev Policy. 13(1):77–92.
   Web of Science ®Google Scholar
• NIDA 2018. Drugs, brains, and behavior: the science of addiction. [accessed 2019 Jun 26]. https://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction
   Google Scholar
• Nordfjaern T. 2011. Relapse patterns among patients with substance use disorders. J Subst Use. 16(4):313–329.
   Web of Science ®Google Scholar
• O’Brien CP. 1984. Use of naltrexone to extinguish opioid-conditioned responses. J Clin Psychiatry. 45(9):53–56.
   PubMed Web of Science ®Google Scholar
• O’Brien CP. 2005. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. AJP. 162(8):1423–1431.
   Web of Science ®Google Scholar
• O’Donovan M.-A, McCallion P, McCarron M, Lynch L, Mannan H, Byrne E. 2019. A narrative synthesis scoping review of life course domains within health service utilisation frameworks. HRB Open Res. 2(6):1–17.
   Google Scholar
• Oliver P, Keen J. 2003. Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poisonings in Sheffield, UK, 1997–2000. Addiction. 98(2):191–197.
   PubMed Web of Science ®Google Scholar
• Oliveto A, Poling J, Mancino M J, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, et al. 2011. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 107(1):131–141.
   PubMed Web of Science ®Google Scholar
• Paliwal P, Hyman SM, Sinha R. 2008. Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire. Drug Alcohol Depend. 93(3):252–259.
   PubMed Web of Science ®Google Scholar
• Pasareanu AR, Vederhus J-K, Opsal A, Kristensen Ø, Clausen T. 2016. Improved drug-use patterns at 6 months post-discharge from inpatient substance use disorder treatment: results from compulsorily and voluntarily admitted patients. BMC Health Serv Res. 16(1):291.
   PubMed Web of Science ®Google Scholar
• Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. 2015. Guidance for conducting systematic scoping reviews. Int J Evid-Based Healthc. 13(3):141–146.
   PubMed Web of Science ®Google Scholar
• Pickard H. 2017. Responsibility without blame for addiction. Neuroethics. 10(1):169–180.
   PubMed Web of Science ®Google Scholar
• Powell J, Dawe S, Richards D, Gossop M, Marks I, Strang J, Gray J. 1993. Can opiate addicts tell us about their relapse risk? Subjective predictors of clinical prognosis. Addict Behav. 18(4):473–490.
   PubMed Web of Science ®Google Scholar
• Prochaska JO, DiClemente CC, Velicer WF, Rossi JS. 1992. Criticisms and concerns of the transtheoretical model in light of recent research. Br J Addict. 87(6):825–828.
   PubMedGoogle Scholar
• Rawson RA, Obert JL, McCann MJ, Marinelli-Casey P. 1993. Relapse prevention models for substance abuse treatment. Psychother Theory Res Pract Training. 30(2):284–298.
   Web of Science ®Google Scholar
• Rhodes D. 2018. Drug and alcohol services cut by £162m as deaths increase [Online]. BBC News England. [accessed 2019 Jul 17]. https://www.bbc.co.uk/news/uk-england-44039996
   Google Scholar
• Robertson JR, Bucknall ABV, Skidmore CA, Roberts JJK, Smith JH. 1989. Remission and relapse in heroin users and implications for management: treatment control or risk reduction. Int J Addict. 24(3):229–246.
   PubMed Web of Science ®Google Scholar
• Roos CR, Bowen S, Witkiewitz K. 2017. Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention. J Consult Clin Psychol. 85(11):1041–1051.
   PubMed Web of Science ®Google Scholar
• Salimi A, Safari F, Mohajerani SA, Hashemian M, Kolahi AA, Mottaghi K. 2014. Long-term relapse of ultra-rapid opioid detoxification. J Addict Dis. 33(1):33–40.
   PubMed Web of Science ®Google Scholar
• Samet S, Fenton MC, Nunes E, Greenstein E, Aharonovich E, Hasin D. 2013. Effects of independent and substance‐induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence. Addiction. 108(1):115–123.
   PubMed Web of Science ®Google Scholar
• Sánchez-Hervás E, Gómez FJS, Villa RS, García-Fernández G, García-Rodríguez O, Romaguera FZ. 2012. Psychosocial predictors of relapse in cocaine-dependent patients in treatment. Span J Psychol. 15(2):748–755.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Oswald LM, Jacks SD, Rustin T, Rhoades HM, Grabowski J. 1997. Relapse prevention treatment for cocaine dependence: group vs. individual format. Addict Behav. 22(3):405–418.
   PubMed Web of Science ®Google Scholar
• Scott CK, Dennis ML, Foss MA. 2005. Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery. Drug Alcohol Depend. 78(3):325–338.
   PubMed Web of Science ®Google Scholar
• Scott CK, Foss MA, Dennis ML. 2005. Pathways in the relapse—treatment—recovery cycle over 3 years. J Subst Abuse Treat. 28(2):S63–S72.
   PubMed Web of Science ®Google Scholar
• Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M. 2018. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: commonalities and specificities across substances. Addict Behav. 83:123–129.
   PubMed Web of Science ®Google Scholar
• Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. 2006. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988–2000. Drug Alcohol Depend. 83(2):147–156.
   PubMed Web of Science ®Google Scholar
• Shi J, Liu YL, Fang YX, Xu GZ, Zhai HF, Lu L. 2006. Traditional Chinese medicine in treatment of opiate addiction. Acta Pharmacol Sin. 27(10):1303–1308.
   PubMed Web of Science ®Google Scholar
• Sinha R. 2001. How does stress increase risk of drug abuse and relapse? Psychopharmacology. 158(4):343–359.
   PubMed Web of Science ®Google Scholar
• Sinha R. 2011. New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep. 13(5):398–405.
   PubMed Web of Science ®Google Scholar
• Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ. 2006. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry. 63(3):324.
   PubMed Web of Science ®Google Scholar
• Smith DG, Ersche KD. 2014. Using a drug-word Stroop task to differentiate recreational from dependent drug use. CNS Spectr. 19(3):247–255.
   PubMed Web of Science ®Google Scholar
• Spanagel R, Mann KF, editors. 2006. Drugs for relapse prevention of alcoholism. Basel (Switzerland): Birkäuser.
   Google Scholar
• Steckler G, Witkiewitz K, Marlatt GA. 2013. Relapse and lapse. In: Miller PM, editor. Principles of addiction: comprehensive addictive behaviors and disorders.1st ed. San Diego (CA): Academic Press. p. 125–132.
   Google Scholar
• Stevens L, Goudriaan AE, Verdejo-Garcia A, Dom G, Roeyers H, Vanderplasschen W. 2015. Impulsive choice predicts short-term relapse in substance-dependent individuals attending an in-patient detoxification programme. Psychol Med. 45(10):2083–2093.
   PubMed Web of Science ®Google Scholar
• Stewart JL, Connolly CG, May AC, Tapert SF, Wittmann M, Paulus MP. 2014. Cocaine dependent individuals with attenuated striatal activation during reinforcement learning are more susceptible to relapse. Psychiatry Res Neuroimaging. 223(2):129–139.
   Web of Science ®Google Scholar
• Su B, Yang L, Wang GY, Wang S, Li S, Cao H, Zhang Y. 2017. Effect of drug-related cues on response inhibition through abstinence: a pilot study in male heroin abstainers. Am J Drug Alcohol Abuse. 43(6):664–670.
   PubMed Web of Science ®Google Scholar
• Tasić JK, Valkanou MK, Đukanović B, Banković D, Janjić V. 2017. Relapse risk factors in heroin addicts treated with naltrexone and naltrexone-behavioural psychotherapy. Int J Ment Health Addict. 16(2):351–365.
   Web of Science ®Google Scholar
• Tate SR, Brown SA, Glasner SV, Unrod M, McQuaid JR. 2006. Chronic life stress, acute stress events, and substance availability in relapse. Addict Res Theory. 14(3):303–322.
   Web of Science ®Google Scholar
• Tavakolian E, Abolghasemi A. 2016. Effects of cognitive restructuring training on neurocognitive functions in opioid addicts. Arch Psych Psych. 18(1):14–21.
   Web of Science ®Google Scholar
• Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJ. 2005. Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend. 79(2):231–240.
   PubMed Web of Science ®Google Scholar
• Tkacz J, Severt J, Kassed C, Ruetsch C. 2012. Clinical differences between opioid abuse classes ameliorated after 1 year of buprenorphine-medication assisted treatment. J Addict Dis. 31(2):100–111.
   PubMed Web of Science ®Google Scholar
• Tucker JA, Vuchinich RE, Gladsjo JA. 1991. Environmental influences on relapse in substance use disorders. Int J Addict. 25(sup7):1017–1050.
   Web of Science ®Google Scholar
• Unnithan S, Gossop M, Strang J. 1992. Factors associated with relapse among opiate addicts in an out-patient detoxification programme. Br J Psychiatry. 161(5):654–657.
   PubMed Web of Science ®Google Scholar
• Van den Brink W, van Ree JM. 2003. Pharmacological treatments for heroin and cocaine addiction. Eur Neuropsychopharmacol. 13(6):476–487.
   Google Scholar
• Vaillant GE. 1988. What can long-term follow-up teach us about relapse and prevention of relapse in addiction? Addiction. 83(10):1147–1157.
   Web of Science ®Google Scholar
• Verdejo-Garcia A, Albein-Urios N, Martinez-Gonzalez JM, Civit E, De la Torre R, Lozano O. 2014. Decision-making impairment predicts 3-month hair-indexed cocaine relapse. Psychopharmacology. 231(21):4179–4187.
   PubMed Web of Science ®Google Scholar
• Wallace BC. 2012. Treating crack cocaine dependence: the critical role of relapse prevention. J Psychoactive Drugs. 24(2):213–222.
   Google Scholar
• Walton MA, Blow FC, Booth BM. 2000. A comparison of substance abuse patients’ and counselors’ perceptions of relapse risk: relationship to actual relapse. J Subst Abuse Treat. 19(2):161–169.
   PubMed Web of Science ®Google Scholar
• Walton MA, Blow FC, Booth BM. 2001. Diversity in relapse prevention needs: gender and race comparisons among substance abuse treatment patients. Am J Drug Alcohol Abuse. 27(2):225–240.
   PubMed Web of Science ®Google Scholar
• Wesson DR, Havassy BE, Smith DE. 1986. Theories of relapse and recovery and their implications for drug abuse treatment. NIDA Res Monogr. 72:5–19.
   PubMedGoogle Scholar
• Williamson A, Darke S, Ross J, Teesson M. 2006. The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug Alcohol Depend. 81(3):293–300.
   PubMed Web of Science ®Google Scholar
• Witkiewitz K, Marlatt GA. 2004. Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. Am Psychol. 59(4):224–235.
   PubMed Web of Science ®Google Scholar
• World Health Organization 2019. Illicit drugs [Online]. Copenhagen, Denmark: WHO Regional Office for Europe. [accessed 2019 Jul 16]. http://www.euro.who.int/en/health-topics/disease-prevention/illicit-drugs/illicit-drugs
   Google Scholar
• Xia Y, Seaman S, Hickman M, Macleod J, Robertson R, Copeland L, McKenzie J, De Angelis D. 2015. Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort. Drug Alcohol Depend. 151:76–83.
   PubMed Web of Science ®Google Scholar
• Yang Z, Xie J, Shao Y-C, Xie C-M, Fu L-P, Li D-J, Fan M, Ma L, Li S-J. 2009. Dynamic neural responses to cue‐reactivity paradigms in heroin‐dependent users: an fMRI study. Hum Brain Mapp. 30(3):766–775.
   PubMed Web of Science ®Google Scholar
• Zemestani M, Ottaviani C. 2016. Effectiveness of mindfulness-based relapse prevention for co-occurring substance use and depression disorders. Mindfulness. 7(6):1347–1355.
   Web of Science ®Google Scholar